Clinical trials
Recherche d’études cliniques
Recherchez uniquement dans les études cliniques enregistrées dans Biomedical Watch.
Études cliniques 3370
| Étude / NCT ⇅ | Molécule ⇅ | Maladie ⇅ | Phase ⇅ | Statut ⇅ | Résultat ⇅ | Sponsor ⇅ | Pays / centres ⇅ | Période ⇅ | Détail |
|---|---|---|---|---|---|---|---|---|---|
| NCT04156243 CD19 CARvac T Cells for Patients With Relapsed / Refractory B Cell Mali… |
CD19 CARvac T cells | SEP | Phase 1 | UNKNOWN | En attente / non publié | iCell Gene Therapeutics | China · Peking University Shenzhen Hospital, Shenzhen… | 2018-02-01 → 2020-02-28 | Ouvrir |
| NCT03720457 Human CD19 Targeted T Cells Injection(CD19 CAR-T) Therapy for Relapsed … |
Human CD19 targeted T Cells Injec… | SEP | Phase 1 | UNKNOWN | En attente / non publié | Hrain Biotechnology Co., Ltd. | China · Fudan University Zhongshan Hospital, Shanghai… | 2018-11-13 → 2023-10 | Ouvrir |
| NCT06279923 CD19-BAFF CAR-T Cells Therapy for Patients With Autoimmune Diseases |
CD19-BAFF Targeted CAR T-cells | SEP | Phase 1 | RECRUITING | En attente / non publié | Zhejiang University | China · The first affiliated hospital of medical coll… | 2024-04-15 → 2027-02-01 | Ouvrir |
| NCT06828042 Safety and Efficacy of Universal CD19-targeting CAR-γδT Cells in Refrac… |
anti-CD19 CAR T cell therapy | SEP | Phase 1/2 | RECRUITING | En attente / non publié | Peking University Third Hospital | China · Peking University Third Hospital, Beijing, Ch… | 2025-07-01 → 2027-12-31 | Ouvrir |
| NCT07582159 Tafasitamab With Acalabrutinib and Venetoclax for the Treatment of Chro… |
Acalabrutinib | SEP | Phase 2 | NOT_YET_RECRUITING | En attente / non publié | City of Hope Medical Center | United States · City of Hope at Irvine Lennar, Irvine… | 2026-12-19 → 2029-04-14 | Ouvrir |
| NCT03824951 Study of Anti-CD19 iCAR NK Cells in Relapsed and Refractory B Cell Lymp… |
Anti-CD19 iCAR NK Cells | SEP | Phase 1 | UNKNOWN | En attente / non publié | Allife Medical Science and Techno… | Non communiqué | 2019-02-01 → 2021-01-01 | Ouvrir |
| NCT04486872 An Exploratory Clinical Trial of Autologous Humanized Anti-cluster of D… |
Autologous humanized anti-CD19 an… | SEP | Phase 1 | UNKNOWN | En attente / non publié | First Affiliated Hospital of Zhej… | China · First Affiliated Hospital of Zhejiang Univers… | 2020-07-25 → 2022-06-25 | Ouvrir |
| NCT06591429 Smoldering Inflammation in MS |
Radiotracer [11C]-CS1P1 | SEP | À vérifier | RECRUITING | En attente / non publié | Washington University School of M… | United States · Barnes Jewish Center for Clinical Ima… | 2024-06-19 → 2027-06-30 | Ouvrir |
| NCT02538926 Etoposide, Prednisone, Vincristine Sulfate, Cyclophosphamide, and Doxor… |
Asparaginase | SEP | Phase 2 | WITHDRAWN | En attente / non publié | University of Washington | United States · Fred Hutchinson Cancer Research Cente… | 2018-07-01 → 2021-07-30 | Ouvrir |
| NCT00003595 Combination Chemotherapy With or Without Monoclonal Antibody Therapy in… |
Filgrastim | SEP | Phase 3 | COMPLETED | En attente / non publié | National Cancer Institute (NCI) | United States · Arthur G. James Cancer Hospital - Ohi… | 1999-01 | Ouvrir |
| NCT07110194 Phase I Clinical Trial of TQB2825 Subcutaneous Injection in CD20-positi… |
TQB2825 Injection (Subcutaneous I… | SEP | Phase 1 | NOT_YET_RECRUITING | En attente / non publié | Shanghai Chia Tai Tianqing Pharma… | China · Beijing Cancer Hospital, Beijing, China | 2025-09 → 2027-12 | Ouvrir |
| NCT04361279 A Study Comparing SIBP-02 and Rituximab Combination With CHOP in Previo… |
SIBP-02 | SEP | Phase 3 | COMPLETED | En attente / non publié | Shanghai Institute Of Biological … | China · The First Affiliated Hospital of College of M… | 2019-07-25 → 2022-05-20 | Ouvrir |
| NCT00818961 Donor Stem Cell Transplant in Treating Patients With High-Risk Hematolo… |
Alemtuzumab | SEP | Phase 2 | TERMINATED | En attente / non publié | Northside Hospital, Inc. | United States · Blood and Marrow Transplant Group of … | 2005-05 → 2012-03 | Ouvrir |
| NCT03379051 Phase I/II Study of Venetoclax or Lenalidomide in Combination With Ubli… |
Venetoclax | SEP | Phase 1/2 | TERMINATED | En attente / non publié | TG Therapeutics, Inc. | United States · TG Therapeutics Investigational Trial… | 2018-03-27 → 2022-06-16 | Ouvrir |
| NCT07854483 A Phase 1b Study of C-CAR168 in Participants With Systemic Sclerosis (S… |
C-CAR168 | SEP | Phase 1 | NOT_YET_RECRUITING | En attente / non publié | RenJi Hospital | Non communiqué | 2027-03 → 2030-03 | Ouvrir |
| NCT01066728 CO2 Inhalation as a New Treatment Modality for Apnea of Prematurity |
Theophylline | SEP | Phase 2/3 | COMPLETED | En attente / non publié | Massachusetts General Hospital | Canada · Health Sciences Centre, Winnipeg, Canada | S… | 2001-08 → 2007-03 | Ouvrir |
| NCT00252863 DESOLO - SiT Peri-Launch: A Comparison of Symbicort Single Inhaler Ther… |
Symbicort, used twice daily (b.i.… | SEP | Phase 3 | COMPLETED | En attente / non publié | AstraZeneca | Germany · Research Site, Amberg, Germany | Research S… | 2004-12 → 2006-05 | Ouvrir |
| NCT01902758 Drug Combination on Exercise Performance at High Altitude |
ambrisentan and theophylline | SEP | Phase 2/3 | COMPLETED | En attente / non publié | University of Montana | United States · Montana Center for Work Physiology an… | 2013-08 → 2013-08 | Ouvrir |
| NCT03115294 CardiomeDIC — Digital Image Correlation in Right Ventricular Evaluation |
Theophylline | SEP | Non applicable | COMPLETED | En attente / non publié | Massachusetts General Hospital | Finland · Tampere University Hospital, Heart Center, … | 2016-05-16 → 2019-10-21 | Ouvrir |
| NCT05163886 Study of Safety, Tolerability, and Biological Activity of LAM-002A in C… |
LAM-002A | Sclérose latérale amyotrophique | Phase 2 | COMPLETED | En attente / non publié | OrphAI Therapeutics | United States · Johns Hopkins University School of Me… | 2021-12-23 → 2025-05-31 | Ouvrir |
| NCT04220190 RAPA-501 Therapy for ALS |
RAPA-501 Autologous T stem cells | Sclérose latérale amyotrophique | Phase 2/3 | RECRUITING | En attente / non publié | Rapa Therapeutics LLC | United States · Massachusetts General Hospital, Bosto… | 2025-01-02 → 2028-07-01 | Ouvrir |
| NCT05039099 A Study to Evaluate, Safety, Tolerability, and PK of AP-101 in Particip… |
AP-101 | Sclérose latérale amyotrophique | Phase 2 | COMPLETED | En attente / non publié | AL-S Pharma | United States, Belgium, Canada, Germany, South Korea,… | 2021-09-02 → 2025-08-13 | Ouvrir |
| NCT05936619 MindEx: A Novel, Multifocal, Cognitive Brain-Machine Interface System |
Mind Extender (MindEx) | Sclérose latérale amyotrophique | Non applicable | RECRUITING | En attente / non publié | Nader Pouratian | United States · UT Southwestern Medical Center, Dalla… | 2026-02-20 → 2031-09-01 | Ouvrir |
| NCT07855211 HORIZON — A Study to Learn About the Safety of BIIB147 and Its Effects … |
BIIB147 | Sclérose latérale amyotrophique | Phase 1/2 | NOT_YET_RECRUITING | En attente / non publié | Biogen | Non communiqué | 2026-10-22 → 2034-01-23 | Ouvrir |
| NCT06726577 TP04HN106 in the Treatment of Patients With Amyotrophic Lateral Scleros… |
TP04HN106 | Sclérose latérale amyotrophique | Phase 1/2 | RECRUITING | En attente / non publié | Talengen Institute of Life Scienc… | China · The First Affiliated Hospital of Soochow Univ… | 2026-06-04 → 2027-04 | Ouvrir |